{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:16:43Z","timestamp":1707524203307},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,27]]},"DOI":"10.7759\/cureus.11198","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T14:49:44Z","timestamp":1603810184000},"source":"Crossref","is-referenced-by-count":0,"title":["Naltrexone-Associated Non-ST-Elevated Myocardial Infarction"],"prefix":"10.7759","author":[{"given":"James C","family":"Gubitosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toby","family":"Terwillliger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adanna","family":"Ukazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Addiction Medicine","author":"Saunders JB","year":"2016","unstructured":"Saunders JB, Conigrave KM, Latt NC, et al.. Addiction Medicine. Oxford University Press, 2016."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0b013e328343d5b7","article-title":"Abrupt opium discontinuation has no significant triggering effect on acute myocardial infarction","volume":"12","author":"Masoomi M","year":"2011","unstructured":"Masoomi M, Zare J, Nasri H, Mirzazadeh A, Sheikhvatan M. Abrupt opium discontinuation has no significant triggering effect on acute myocardial infarction. J Cardiovasc Med. 2011, 12:234-238. 10.2459\/JCM.0b013e328343d5b7","journal-title":"J Cardiovasc Med"},{"key":"ref3","article-title":"Acute myocardial infarction following naltrexone consumption; a case report","volume":"5","author":"Dadpour B","year":"2017","unstructured":"Dadpour B, Gholoobi A, Tajoddini S, Habibi A. Acute myocardial infarction following naltrexone consumption; a case report. Emerg (Tehran). 2017, 5:e45.","journal-title":"Emerg (Tehran)"},{"key":"ref4","unstructured":"Opioid antagonist. (2013). Accessed. October 27, 2020: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/018932s017lbl.pdf."},{"key":"ref5","article-title":"Opioid Therapy in the 21st Century","author":"Smith HS","year":"2013","unstructured":"Smith HS. Opioid Therapy in the 21st Century. Oxford University Press, 2013."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.173823","article-title":"Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal","volume":"336","author":"Paronis CA","year":"2011","unstructured":"Paronis CA, Bergman J. Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal. J Pharmacol Exp Ther. 2011, 336:488-495. 10.1124\/jpet.110.173823","journal-title":"J Pharmacol Exp Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0163-7258(00)00106-6","article-title":"Opioids and cardioprotection","volume":"89","author":"Schultz JE","year":"2001","unstructured":"Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Thera. 2001, 89:123-137. 10.1016\/s0163-7258(00)00106-6","journal-title":"Pharmacol Thera"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2009.04.009","article-title":"Myocardial apoptosis and infarction after ischemia\/reperfusion are attenuated by kappa-opioid receptor agonist","volume":"40","author":"Rong F","year":"2009","unstructured":"Rong F, Peng Z, Ming-Xiang Y, et al.. Myocardial apoptosis and infarction after ischemia\/reperfusion are attenuated by kappa-opioid receptor agonist. Arch Med Res. 2009, 40:227-234. 10.1016\/j.arcmed.2009.04.009","journal-title":"Arch Med Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e3181b92201","article-title":"Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion","volume":"109","author":"Gross ER","year":"2009","unstructured":"Gross ER, Hsu AK, Gross GJ. Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion. Anesth Analg. 2009, 109:1395-1402. 10.1213\/ANE.0b013e3181b92201","journal-title":"Anesth Analg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10517-010-1000-6","article-title":"Opioid peptide deltorphin II simulates the cardioprotective effect of ischemic preconditioning: role of \u03b42-opioid receptors, protein kinase C, and KATP channels","volume":"149","author":"Maslov LN","year":"2010","unstructured":"Maslov LN, Barzakh EI, Krylatov AV, et al.. Opioid peptide deltorphin II simulates the cardioprotective effect of ischemic preconditioning: role of \u03b42-opioid receptors, protein kinase C, and KATP channels. Bull Exp Biol Med. 2010, 149:591-593. 10.1007\/s10517-010-1000-6","journal-title":"Bull Exp Biol Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-011-0734-0","article-title":"Role of central and peripheral opioid receptors in the cardioprotection of intravenous morphine preconditioning","volume":"180","author":"Lu Y","year":"2011","unstructured":"Lu Y, Dong C, Yu J, Li L. Role of central and peripheral opioid receptors in the cardioprotection of intravenous morphine preconditioning. Irish J Med Sci. 2011, 180:881. 10.1007\/s11845-011-0734-0","journal-title":"Irish J Med Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2005.07.036","article-title":"Opioids and cardioprotection: the impact of morphine and fentanyl on recovery of ventricular function after cardiopulmonary bypass","volume":"20","author":"Murphy GS","year":"2006","unstructured":"Murphy GS, Szokol JW, Marymont JH, Avram MJ, Vender JS. Opioids and cardioprotection: the impact of morphine and fentanyl on recovery of ventricular function after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2006, 20:493-502. 10.1053\/j.jvca.2005.07.036","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000264108.47280.f5","article-title":"The effects of morphine and fentanyl on the inflammatory response to cardiopulmonary bypass in patients undergoing elective coronary artery bypass graft surgery","volume":"104","author":"Murphy GS","year":"2007","unstructured":"Murphy GS, Szokol JW, Marymont JH, Avram MJ, Vender JS. The effects of morphine and fentanyl on the inflammatory response to cardiopulmonary bypass in patients undergoing elective coronary artery bypass graft surgery. Anesth Analg. 2007, 104:1334-1342. 10.1213\/01.ane.0000264108.47280.f5","journal-title":"Anesth Analg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-015-1998-8","article-title":"\u03ba-Opioid receptors are involved in enhanced cardioprotection by combined fentanyl and limb remote ischemic postconditioning","volume":"29","author":"Xu Y-C","year":"2015","unstructured":"Xu Y-C, Li R-P, Xue F-S, et al.. \u03ba-Opioid receptors are involved in enhanced cardioprotection by combined fentanyl and limb remote ischemic postconditioning. J Anesth. 2015, 29:535-543. 10.1007\/s00540-015-1998-8","journal-title":"J Anesth"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.05.043","article-title":"\u03ba-opioid receptor activation protects against myocardial ischemia-reperfusion injury via AMPK\/Akt\/eNOS signaling activation","volume":"833","author":"Zhang S","year":"2018","unstructured":"Zhang S, Zhou Y, Zhao L, et al.. \u03ba-opioid receptor activation protects against myocardial ischemia-reperfusion injury via AMPK\/Akt\/eNOS signaling activation. Eur J Pharmacol. 2018, 833:100-108. 10.1016\/j.ejphar.2018.05.043","journal-title":"Eur J Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/42238-naltrexone-associated-non-st-elevated-myocardial-infarction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:19:22Z","timestamp":1707506362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/42238-naltrexone-associated-non-st-elevated-myocardial-infarction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.11198","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,27]]}}}